Title:
PYRAZINAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USES THEREOF AS TYK2 INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2024/088282
Kind Code:
A1
Abstract:
The present invention provides a pyridazine compound as shown in formula (II), a preparation method therefor, and uses thereof. Also disclosed are uses of the compound of the present invention or the pharmaceutical composition thereof in preparation of a medicine for preventing and/or treating TYK2-mediated diseases.
Inventors:
XU XIN (CN)
ZHOU XIAOBO (CN)
LI QIANG (CN)
ZHANG XIAOJUAN (CN)
GUO FENGYING (CN)
CHEN JIA (CN)
JIANG XIANGMEI (CN)
LI XIANNI (CN)
ZHOU XIAOBO (CN)
LI QIANG (CN)
ZHANG XIAOJUAN (CN)
GUO FENGYING (CN)
CHEN JIA (CN)
JIANG XIANGMEI (CN)
LI XIANNI (CN)
Application Number:
PCT/CN2023/126345
Publication Date:
May 02, 2024
Filing Date:
October 25, 2023
Export Citation:
Assignee:
ZHEJIANG HUAHAI PHARM CO LTD (CN)
SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO LTD (CN)
SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO LTD (CN)
International Classes:
C07D403/12; A61K31/501; A61P1/00; A61P17/00; A61P37/00; C07D401/12; C07D417/14
Domestic Patent References:
| WO2020156311A1 | 2020-08-06 |
Foreign References:
| CN110475774A | 2019-11-19 | |||
| CN113968846A | 2022-01-25 | |||
| US20220009910A1 | 2022-01-13 |
Download PDF:
Previous Patent: COMPOSITE STRUCTURE ELASTIC TUBE AND MANUFACTURING METHOD THEREFOR
Next Patent: HUMANIZED L1CAM ANTIBODY-DRUG CONJUGATE
Next Patent: HUMANIZED L1CAM ANTIBODY-DRUG CONJUGATE